Publication | Closed Access

Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo

Percutaneous Coronary InterventionCardiovascular DiseaseAtherosclerosisMedicineIntramural DeliveryEndothelial DysfunctionVascular BiologyPharmacotherapyBiomedical EngineeringNeovascularizationPharmacologyCardiologyRestenotic ChangesCoronary ArteryCoronary Artery Disease